Overview Dividends

(NVST) Envista Holdings - Ratings and Ratios

Exchange: NYSE • Country: United States • Currency: USD • Type: Common Stock • ISIN: US29415F1049

Implants, Aligners, Imaging, Instruments, Materials

NVST EPS (Earnings per Share)

EPS Growth (3Y CAGR): -19.37%
EPS Trend (3Y Correlation): -68.6%

NVST Revenue

Revenue Growth (3Y CAGR): 2.87%
Revenue Trend (3Y Correlation): 0.2%

Description: NVST Envista Holdings November 07, 2025

Envista Holdings Corp (NVST) is a U.S.–based dental-technology company that designs, manufactures and sells a broad portfolio of products across two primary segments: Specialty Products & Technologies and Equipment & Consumables. The Specialty segment supplies implant systems, guided-surgery tools, biomaterials, prosthetics, orthodontic brackets, wires and digital orthodontic solutions, together with software suites (DTX Studio Implant, Lab, Clinic) under brands such as Nobel Biocare, Ormco and Damon. The Equipment & Consumables segment delivers digital imaging, endodontic, restorative, and infection-prevention supplies-including Dexis imaging units, Kerr bonding agents and CaviWipes-targeting dental offices, clinics and hospitals.

Key industry metrics that shape Envista’s outlook include: (1) the global dental market, projected to exceed $45 billion by 2027, driven by an aging population and increasing demand for cosmetic dentistry; (2) digital dentistry adoption, with implant-guided surgery and intra-oral scanners growing at ~12% CAGR, which directly benefits Envista’s software-enabled product lines; and (3) the company’s recent financial performance-FY 2023 revenue of $1.5 billion, a 6% YoY increase, and an operating margin of ~14%-suggesting modest scalability but also highlighting sensitivity to raw-material cost inflation and foreign-exchange volatility in its China operations.

For a deeper quantitative assessment, you may find the ValueRay platform’s detailed valuation model useful.

NVST Stock Overview

Market Cap in USD	3,383m
Sub-Industry	Health Care Equipment
IPO / Inception	2019-09-18

NVST Stock Ratings

Growth Rating	-50.1%
Fundamental	48.8%
Dividend Rating	-
Return 12m vs S&P 500	-20.3%
Analyst Rating	3.29 of 5

NVST Dividends

Currently no dividends paid

NVST Growth Ratios

Growth Correlation 3m	-76.1%
Growth Correlation 12m	7.8%
Growth Correlation 5y	-83.9%
CAGR 5y	-20.17%
CAGR/Max DD 3y (Calmar Ratio)	-0.31
CAGR/Mean DD 3y (Pain Ratio)	-0.48
Sharpe Ratio 12m	-0.41
Alpha	-25.80
Beta	1.016
Volatility	32.68%
Current Volume	2854.7k
Average Volume 20d	1945.8k
Stop Loss	18.7 (-3.9%)
Signal	0.88

Piotroski VR‑10 (Strict, 0-10) 4.0

Net Income (53.8m TTM) > 0 and > 6% of Revenue (6% = 153.2m TTM)

FCFTA 0.05 (>2.0%) and ΔFCFTA -0.72pp (YES ≥ +1.0pp, WARN ≥ +0.5pp)

NWC/Revenue 44.69% (prev 39.49%; Δ 5.21pp) (YES ≤20% & Δ≤-1pp; WARN ≤25% & Δ≤0 oder ≤40% & Δ≤-3pp)

CFO/TA 0.05 (>3.0%) and CFO 292.1m > Net Income 53.8m (YES >=105%, WARN >=100%)

Net Debt (485.6m) to EBITDA (258.8m) ratio: 1.88 <= 3.0 (WARN <= 3.5)

Current Ratio 2.44 (target 1.5–3.0; WARN 1.2–<1.5 or >3.0–5.0; CFO/TA gate active)

Outstanding Shares last Quarter (169.9m) change vs 12m ago -1.28% (target <= -2.0% for YES)

Gross Margin 54.68% (prev 54.75%; Δ -0.07pp) >=18% & Δ>=+0.5pp (WARN >=15% & Δ>=0)

Asset Turnover 45.99% (prev 46.59%; Δ -0.60pp) >=50% & Δ>=+2pp (WARN >=35% & Δ>=0)

Interest Coverage Ratio 4.17 (EBITDA TTM 258.8m / Interest Expense TTM 39.1m) >= 6 (WARN >= 3)

Altman Z'' 1.03

(A) 0.20 = (Total Current Assets 1.93b - Total Current Liabilities 793.9m) / Total Assets 5.66b

(B) -0.08 = Retained Earnings (Balance) -443.0m / Total Assets 5.66b

(D) -0.22 = Book Value of Equity -564.8m / Total Liabilities 2.53b

Total Rating: 1.03 = (6.56 * A) + (3.26 * B) + (6.72 * C) + (1.05 * D)

ValueRay F-Score (Strict, 0-100) 48.75

1. Piotroski 4.0pt = -1.0

2. FCF Yield 6.67% = 3.33

3. FCF Margin 10.10% = 2.53

4. Debt/Equity 0.51 = 2.37

5. Debt/Ebitda 1.88 = 0.24

6. ROIC - WACC (= -4.36)% = -5.46

7. RoE 1.77% = 0.15

8. Rev. Trend 0.17% = 0.01

9. EPS Trend -68.60% = -3.43

What is the price of NVST shares?

As of November 08, 2025, the stock is trading at USD 19.45 with a total of 2,854,700 shares traded.
Over the past week, the price has changed by -4.42%, over one month by -4.75%, over three months by -3.19% and over the past year by -9.11%.

Is Envista Holdings a good stock to buy?

No, based on ValueRay´s Fundamental Analyses, Envista Holdings (NYSE:NVST) is currently (November 2025) a stock to sell. It has a ValueRay Fundamental Rating of 48.75 and therefor a negative outlook according to the companies health.
Based on momentum, paid dividends and discounted-cash-flow analyses, the fair value of NVST is around 15.31 USD . This means that NVST is currently overvalued and has a potential downside of -21.29%.

Is NVST a buy, sell or hold?

Envista Holdings has received a consensus analysts rating of 3.29. Therefor, it is recommend to hold NVST.

Strong Buy: 3
Buy: 0
Hold: 10
Sell: 0
Strong Sell: 1

What are the forecasts/targets for the NVST price?

Issuer	Target	Up/Down from current
Wallstreet Target Price	21.4	10.1%
Analysts Target Price	21.4	10.1%
ValueRay Target Price	16.8	-13.6%

NVST Fundamental Data Overview October 27, 2025

Market Cap USD = 3.38b (3.38b USD * 1.0 USD.USD)
P/E Trailing = 63.625
P/E Forward = 16.8067
P/S = 1.3253
P/B = 1.089
Beta = 1.016
Revenue TTM = 2.55b USD
EBIT TTM = 163.2m USD
EBITDA TTM = 258.8m USD
Long Term Debt = 1.45b USD (from longTermDebt, last quarter)
Short Term Debt = 36.1m USD (from shortTermDebt, last quarter)
Debt = 1.60b USD (from shortLongTermDebtTotal, last quarter)
Net Debt = 485.6m USD (from netDebt column, last quarter)
Enterprise Value = 3.87b USD (3.38b + Debt 1.60b - CCE 1.11b)
Interest Coverage Ratio = 4.17 (Ebit TTM 163.2m / Interest Expense TTM 39.1m)
FCF Yield = 6.67% (FCF TTM 257.9m / Enterprise Value 3.87b)
FCF Margin = 10.10% (FCF TTM 257.9m / Revenue TTM 2.55b)
Net Margin = 2.11% (Net Income TTM 53.8m / Revenue TTM 2.55b)
Gross Margin = 54.68% ((Revenue TTM 2.55b - Cost of Revenue TTM 1.16b) / Revenue TTM)
Gross Margin QoQ = 54.27% (prev 54.47%)
Tobins Q-Ratio = 0.68 (Enterprise Value 3.87b / Total Assets 5.66b)
Interest Expense / Debt = 0.50% (Interest Expense 8.00m / Debt 1.60b)
Taxrate = 35.14% (14.3m / 40.7m)
NOPAT = 105.9m (EBIT 163.2m * (1 - 35.14%))
Current Ratio = 2.44 (Total Current Assets 1.93b / Total Current Liabilities 793.9m)
Debt / Equity = 0.51 (Debt 1.60b / totalStockholderEquity, last quarter 3.14b)
Debt / EBITDA = 1.88 (Net Debt 485.6m / EBITDA 258.8m)
Debt / FCF = 1.88 (Net Debt 485.6m / FCF TTM 257.9m)
Total Stockholder Equity = 3.05b (last 4 quarters mean from totalStockholderEquity)
RoA = 0.95% (Net Income 53.8m / Total Assets 5.66b)
RoE = 1.77% (Net Income TTM 53.8m / Total Stockholder Equity 3.05b)
RoCE = 3.63% (EBIT 163.2m / Capital Employed (Equity 3.05b + L.T.Debt 1.45b))
RoIC = 2.37% (NOPAT 105.9m / Invested Capital 4.46b)
WACC = 6.74% (E(3.38b)/V(4.98b) * Re(9.76%) + D(1.60b)/V(4.98b) * Rd(0.50%) * (1-Tc(0.35)))
Discount Rate = 9.76% (= CAPM, Blume Beta Adj.)
Shares Correlation 3-Years: -33.33 | Cagr: -0.53%
[DCF Debug] Terminal Value 74.17% ; FCFE base≈269.3m ; Y1≈302.0m ; Y5≈403.0m
Fair Price DCF = 31.27 (DCF Value 5.20b / Shares Outstanding 166.2m; 5y FCF grow 14.07% → 3.0% )
EPS Correlation: -68.60 | EPS CAGR: -19.37% | SUE: 0.43 | # QB: 0
Revenue Correlation: 0.17 | Revenue CAGR: 2.87% | SUE: 3.73 | # QB: 2

Additional Sources for NVST Stock

News: Wall Street Journal | Benzinga | Yahoo Finance
Tweets: X | Stocktwits
Fund Manager Positions: Dataroma | Stockcircle